Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma

The purpose of this study is to test a new medication called Mosunetuzumab to see if it can help people with Extranodal Marginal Zone Lymphoma (EMZL). This study will include people who have not yet received any treatment for cancer and whose cancer is in stage I-IV. This study will help doctors understand if Mosunetuzumab improves outcomes in people with EMZL and if it is safe to use.

Participants needed: 35
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Izidore Lossos, MDUpdated: Nov 3, 2025Locations: 1
Eligibility criteria

Men and women aged 18 years or older at the time of signing informed consent. [+33]

Evidence of diffuse large B cell lymphoma (DLBCL) transformation. Participants w... [+37]

Read more
Status: Recruiting

Epcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)

The purpose of this study is to assess if an investigational treatment of Epcoritamab will be beneficial for patients with Marginal Zone Lymphoma (MZL).

Participants needed: 25
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Izidore Lossos, MDUpdated: Oct 28, 2025Locations: 1
Eligibility criteria

Men and women aged 18 years or older at the time of signing informed consent. [+12]

Threatened extranodal organ function, especially for extranodal MZL [+60]

Read more